THREAD
← Back

THREAD Launches the Next Generation of Configurable SaaS Technology Features to Address Industry Challenges in Complex Clinical Research

Enhanced from experience supporting the most complex research environments in more than 60 countries and 100 languages, THREAD introduces the next major release of their platform with the industry’s most comprehensive set of advanced, fully configurable features

CARY, N.C., 07 MAY2025 – Since its initial launch in 2018, THREAD’s no-code SaaS research platform has been focused on innovating technology implementation and endpoint data capture to enable clinical research for everyone, everywhere. Today, the company announces its latest expansion of capabilities, empowering a unified pathway to reduce cost, risks, and time in designing and deploying research studies.

THREAD now offers unparalleled levels of configurability with their SaaS platform supporting full-service to self-service approaches. This next version of the platform features marks a significant advancement in SaaS research technology, providing users with a wider range of features designed to enhance the control and experience in utilizing the THREAD platform. Key features of this technology release include:

  • Advanced Versioning with Precision Control: Personalize activities for any participant while seamlessly creating mid-study changes without disruption
  • Enhanced Participant App with a Next Level Omni-channel Experience: Enable a single implementation pathway for IOS/Android and web, with the ability to interchangeably shift between modalities as their day changes in a more simplified way
  • Next Generation Data and Analytics with Customizable Reporting: Tailored health insights for every endpoint, to drive responsiveness and avoid costly risks

"This platform release represents the culmination of our recent user insights from working across clients, therapeutic areas, and countries. We listened intently to feedback from our customers, participants, research sites, and study teams on complex, global clinical trials to enable these solutions,” said John Reites, Co-founder and CEO at THREAD. “A part of our mission remains to drive increased efficiencies in clinical research – this is another step to delivering on that mission for our clients and research stakeholders.”

Learn more about THREAD’s latest platform release, see a demo of the latest features, and explore how it supports reducing cost, risk and time in deploying research studies: discover.threadresearch.com/platform-release

##

About THREAD

THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. The companies’ uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient. THREAD is recognized as a leader by Everest Group’s Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021/2022/2023 and positioned in the Leader's Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022. Visit THREADresearch.com to learn more.

Media Contact

Les Yates
THREAD
media@THREADresearch.com